Navigation Links
Startup to develop new solid-state technology at UCLA for use in medical imaging
Date:4/2/2010

While today many medical-imaging needs are being met with traditional vacuum tubebased technology, large segments of the X-rayimaging market are poorly served, and there is widespread demand for both performance improvements and cost reductions.

Based on groundbreaking patented technology licensed from UCLA, startup company Radius Health is developing a lightweight, flat-panel X-ray source Microemitter Array X-rays (MAX) technology that has the potential to address these needs by enabling new X-ray imaging applications while lowering the cost of traditional applications.

The startup has been selected to move into the UCLA on-campus incubator space at the California NanoSystems Institute to develop a lightweight X-ray emitter employing MAX technology an X-ray source on a chip capable of delivering the same spectrum as traditional sources.

The MAX technology was developed by Gil Travish, Ph.D., a research scientist in the UCLA Department of Physics and Astronomy, and his colleagues James Rosenzweig, a UCLA professor of physics, and Rodney Yoder, an assistant professor of physics at Manhattanville College in New York.

The MAX technology works like this: Using an array of particle sources from microfabricated structures, parallel X-rays are generated uniformly across a flat panel. The MAX source, which can be produced using the current generation of semiconductor foundry processes, generates diagnostic X-rays without the need for fragile vacuum tubes and bulky, expensive power electronics and radioactive materials.

The technology has the potential to deliver advanced and potentially safer imaging options than are available with current commercial X-ray systems, and to extend the 'application space' of X-ray radiology.

"Moving our development activities into CNSI is a real landmark moment for us," said Mark Evans, CEO for Radius Health. "The access to the facilities and knowledge will greatly help us accelerate our product to market and bring this key technology nearer to deployment in clinical systems."

Radius Health expects to make extensive use of the microfabrication facilities at the new Integrated Systems Nanofabrication Cleanroom at CNSI.

The use of pyroelectric emission is important, as the voltage required to generate electrons within the X-ray production process is produced within a crystal, eliminating the need for 'clean' power supplies, transformers, high-voltage electronics and the associated shielding required and most importantly, fragile vacuum tubes.

Unlike past efforts with pyroelectric-based sources, Radius Health is able to control the emission of electrons and thus maintain a stable and controlled emission of X-rays, which allows this type of source to be applied to clinical applications.

The journey from vacuum tubes to flat panels could be as transformational in X-rays as it has been in visual displays.

"In most areas of electronic product development, such as computing, displays and radar, solid-state technology has replaced vacuum-tube technology due to the improvements in reliability, energy consumption and portability," Travish said. "We see this story being extended to X-ray sources."


'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Related medicine news :

1. Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York
2. Informatics experts contribute to special Health Affairs edition on e-health in the developing world
3. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
4. Developing a cyberinfrastructure for comparative effectiveness in cancer research
5. Oakland University William Beaumont School of Medicine Reaches Development Milestone
6. Electrical Muscle Stimulation Proven to Enhance Muscle Development and Sports Performance
7. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
8. New York City Surgeon Develops All-Natural Treatment for Wrinkles and Scars
9. FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries
10. University of Alberta researchers develop drug interface to save lives
11. The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide Call for Proposals From Life Science Technologies in Need of Funding and Active Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: